Fund Evaluator:
ETRACS 2x Leveraged US Value Fctr TR ETN (IWDL)
Follow This Fund
Other
Global Asset Class
Miscellaneous
Fund Group
Trading--Leveraged Equity
Category
$0.000
NAV (as of )
$0.00
Minimum Initial
0.95% C
Expense Ratio
$6 Mil
Assets
Open
Status
na
12b-1 Fee
0.00%
TTM Yield
0.00%
Max Load
na
Portfolio Turnover
Best Performing in Trading--Leveraged Equity Over the Last Year
| 125.2% | ProFunds UltraJapan Inv (UJPIX) |
| 113.0% | ProFunds Biotechnology UltraSector Inv (BIPIX) |
| 104.4% | Oil Equipment&Svcs UltraSector Pro Inv (OEPIX) |
| 100.6% | ProFunds Pharmaceuticals UltraSector Inv (PHPIX) |
| 98.9% | ProFunds UltraLatin America Inv (UBPIX) |
Data as of 7/31/2026
7.0% A
1-Mo Return
16.9% A
3-Mo Return
39.3% A
YTD Return
60.2% B
1-Yr Return
28.3% B
3-Yr Return
15.8% B
5-Yr Return
0.48 A
Category Risk Index
2.06
Total Risk Index
Fund Details
Fund Family
UBS
Inception Date
2/5/2021
Share Class Type
Equity Investment Style
na
Bond Investment Style
na
Socially Responsible Fund
No
Index Fund
Yes
Benchmark Index
Russell 1000 Value TR USD: 200%
Additional Fund Details
ETRACS 2x Leveraged US Value Fctr TR ETN Overview
IWDL Trailing NAV Total Returns Data as of 7/31/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| IWDL Return (NAV) | 7.0% | 16.9% | 60.2% | 28.3% | 15.8% | na |
| IWDL Grade | A | A | B | B | B | na |
| +/- Category | 9.7% | 14.0% | 20.9% | 7.2% | 6.1% | na |
| Trading--Leveraged Equity Avg | -2.7% | 2.9% | 39.4% | 21.1% | 9.8% | 14.0% |
| IWDL Tax Cost Ratio | na | na | 0.0% | 0.0% | 0.0% | na |
IWDL Annual NAV Total ReturnsData as of 7/31/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| IWDL Return (NAV) | 39.3% | 24.8% | 20.7% | 13.4% | -21.2% | na | na | na | na | na | na |
| IWDL Grade | A | C | C | D | B | na | na | na | na | na | na |
| +/- Category | 22.1% | -6.5% | 2.1% | -22.5% | 7.7% | na | na | na | na | na | na |
| Trading--Leveraged Equity Avg | 17.1% | 31.2% | 18.6% | 36.0% | -28.9% | 26.9% | 23.4% | 44.0% | -17.6% | 37.7% | 19.3% |
| Risk Measures | |
| Standard Deviation: | 25.3% |
| Total Risk Index: | 2.06 - High |
| Category Risk Index: | 0.48 - Low |
| Category Risk Grade: | A (10% Rank) |
| Beta: | 1.58 |
| R-Squared: | 67% |
| Leveraged Fund: | Yes |
| Inverse Fund: | No |
| Portfolio Characteristics | |
| Equity Investment Style: | na |
| Bond Investment Style: | na |
| Yield: | 0.0% |
| Dividend Distribution: | Annually |
| Cap Gains Distribution: | |
| Total Assets: | $6 Mil |
| Fund Total Assets: | $ 7 Mil |
| Share Class Type: | |
| Portfolio Turnover: | na |
Management Team
| Number of Managers: 1 | |||
| Longest Tenure: 5.5 years | |||
| Average Tenure: 5.5 years | |||
| Managers (Year): Manager No (2021) | |||
Portfolio Composition (as of )
| # of Holdings: | |
| % in Top 10 Holdings: | 0.0% |
| Fund is Non-Diversified: | No |
| % in Foreign Issues: | 0.0% |
Portfolio Allocation |
|
| Domestic Stock: | 0.0% |
| Foreign Stock: | 0.0% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | 0.0% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | 0.0% |
| Cash: | 0.0% |
Purchase Information
| Fund Family: | UBS |
| Phone Number: | 800-587-2111 |
| Website: | www.ubs.com/investor-relations |
| Status: | Open |
| Inception Date: | February 5, 2021 |
| Min. Initial Purchase: | $ 0 |
| Min. Initial IRA Purchase: | $ 0 |
| True No-Load: | Yes |
| Front Load Maximum: | 0.00% |
| Deferred Charge Maximum: | 0.00% |
| Redemption Charge Maximum: | 0.00% |
| 12b-1 Fee: | na |
Expenses and Fees | |
| Expense Ratio (%): | 0.95% ( Rating : High ) |
| Category Average Expense Ratio (%): | 2.03% |
| Share Class: | ETRACS 2x Leveraged US Value Fctr TR ETN |
| Min. Subsequent Purchase: | $ 0 |
| Min. Subsequent IRA Purchase: | $ 0 |
Copyright 2026 American Association of Individual Investors and Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.